Corline Biomedical AB Total Liabilities

Latest as of June 2026: Skr15.18 Million SEK ≈ $1.63 Million USD

Corline Biomedical AB total liabilities. Based on the latest financial reports, Corline Biomedical AB (CLBIO) has total liabilities worth Skr15.18 Million SEK (≈ $1.63 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Corline Biomedical AB (CLBIO) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Corline Biomedical AB (2012–2025)

Total liabilities of Corline Biomedical AB from 2012 to 2025. This chart illustrates how Corline Biomedical AB's total liabilities have evolved over time, based on quarterly financial data.

Corline Biomedical AB Competitors by Total Liabilities

The table below lists competitors of Corline Biomedical AB ranked by their total liabilities.

Company	Country	Total Liabilities
Oricom Inc KQ:010470	Korea	₩112.61 Billion
Chi Hua Fitness Co Ltd TWO:1593	Taiwan	NT$688.93 Million
CHUNGDAHM Learning Inc KQ:096240	Korea	₩129.42 Billion
Natura City Developments Tbk PT JK:CITY	Indonesia	Rp180.80 Billion
Almondz Global Securities Limited NSE:ALMONDZ	India	Rs-2.93 Billion
Estoril Sol SGPS SA LS:ESON	Portugal	€205.95 Million
XTI Aerospace, Inc. NASDAQ:XTIA	USA	$91.97 Million
InCity Immobilien AG XETRA:IC8	Germany	€80.95 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Corline Biomedical AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see CLBIO asset base.

Liquidity & Leverage Metrics

Corline Biomedical AB Total Liabilities Ratios Explained

Corline Biomedical AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	6.48	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.15	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.13	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Corline Biomedical AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Corline Biomedical AB (2012–2025)

The table below shows the annual total liabilities of Corline Biomedical AB from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr4.82 Million ≈ $518.60K	-38.60%
2024-12-31	Skr7.85 Million ≈ $844.57K	+15.60%
2023-12-31	Skr6.79 Million ≈ $730.60K	-5.63%
2022-12-31	Skr7.19 Million ≈ $774.19K	-23.69%
2021-12-31	Skr9.43 Million ≈ $1.01 Million	+50.83%
2020-12-31	Skr6.25 Million ≈ $672.60K	+40.99%
2019-12-31	Skr4.43 Million ≈ $477.06K	-44.26%
2018-12-31	Skr7.95 Million ≈ $855.87K	+44.57%
2017-12-31	Skr5.50 Million ≈ $592.00K	+117.52%
2016-12-31	Skr2.53 Million ≈ $272.16K	-32.46%
2015-12-31	Skr3.74 Million ≈ $402.98K	-66.83%
2014-12-31	Skr11.29 Million ≈ $1.21 Million	+95.96%
2013-12-31	Skr5.76 Million ≈ $619.91K	-48.05%
2012-12-31	Skr11.09 Million ≈ $1.19 Million	--

About Corline Biomedical AB

ST:CLBIO Sweden Biotechnology

Market Cap

$37.69 Million

Skr350.18 Million SEK

Market Cap Rank

#22733 Global

#427 in Sweden

Share Price

Skr13.40

Change (1 day)

-2.55%

52-Week Range

Skr13.40 - Skr19.80

All Time High

Skr28.20